{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T16:16:51Z","timestamp":1775146611918,"version":"3.50.1"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1097\/wnf.0b013e3181ebd109","type":"journal-article","created":{"date-parts":[[2010,9,9]],"date-time":"2010-09-09T10:17:55Z","timestamp":1284027475000},"page":"223-226","source":"Crossref","is-referenced-by-count":12,"title":["A Pilot Efficacy and Tolerability Trial of Memantine for Essential Tremor"],"prefix":"10.1097","volume":"33","author":[{"given":"Adrian","family":"Handforth","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yvette","family":"Bordelon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven J.","family":"Frucht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnulfo","family":"Quesada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-2-20210203","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0022-510X(93)90047-3","article-title":"Glucose metabolism in the brain of patients with essential tremor.","volume":"114","author":"Hallett","year":"1993","journal-title":"J Neurol Sci"},{"key":"R2-2-20210203","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/ana.410340115","article-title":"A positron emission tomography study of essential tremor: evidence for overactivity of cerebellar connections.","volume":"34","author":"Jenkins","year":"1993","journal-title":"Ann Neurol"},{"key":"R3-2-20210203","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/BF01273153","article-title":"Change in the concentrations of amino acids in CSF and serum of patients with essential tremor.","volume":"103","author":"Mally","year":"1996","journal-title":"J Neural Transm"},{"key":"R4-2-20210203","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1523\/JNEUROSCI.14-02-00667.1994","article-title":"Light and electron microscope distribution of the NMDA receptor subunit NMDAR1 in the rat nervous system using a selective anti-peptide antibody.","volume":"14","author":"Petralia","year":"1994","journal-title":"J Neurosci"},{"key":"R5-2-20210203","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.brainres.2005.10.054","article-title":"Differential expression of NMDA and AMPA\/KA receptor subunits in the inferior olive of postnatal rats.","volume":"1067","author":"Chen","year":"2006","journal-title":"Brain Res"},{"key":"R6-2-20210203","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0006-8993(73)90768-3","article-title":"Rhythmic activity induced by harmaline in the olivo-cerebello-bulbar system of the cat.","volume":"53","author":"de Montigny","year":"1973","journal-title":"Brain Res"},{"key":"R7-2-20210203","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1023\/B:NEUR.0000029648.81071.20","article-title":"Harmaline-induced climbing fiber activation causes amino acid and peptide release in the rodent cerebellar cortex and a unique temporal pattern of Fos expression in the olivo-cerebellar pathway.","volume":"33","author":"Beitz","year":"2004","journal-title":"J Neurocytol"},{"key":"R8-2-20210203","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1161\/01.STR.29.2.499","article-title":"Activation of cerebellar climbing fibers increases cerebellar blood flow: role of glutamate receptors, nitric oxide, and cGMP.","volume":"29","author":"Yang","year":"1998","journal-title":"Stroke"},{"key":"R9-2-20210203","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0006-8993(96)01148-1","article-title":"Harmaline-induced tremor and impairment of learning are both blocked by dizocilpine in the rabbit.","volume":"745","author":"Du","year":"1997","journal-title":"Brain Res"},{"key":"R10-2-20210203","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/0028-3908(82)90126-5","article-title":"Antagonists of excitatory amino acids and cyclic guanosine monophosphate in cerebellum.","volume":"21","author":"Wood","year":"1982","journal-title":"Neuropharmacology"},{"key":"R11-2-20210203","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0014-2999(95)00795-4","article-title":"Effects of 7-nitroindazole, NG-nitro-l-arginine, and d-CPPene on harmaline-induced postural tremor, N-methyl-d-aspartate-induced seizures, and lisuride-induced rotations in rats with nigral 6-hydroxydopamine lesions.","volume":"299","author":"Eblen","year":"1996","journal-title":"Eur J Pharmacol"},{"key":"R12-2-20210203","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ejphar.2009.05.031","article-title":"Pharmacological characterization of harmaline-induced tremor activity in mice.","volume":"616","author":"Paterson","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"R13-2-20210203","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1358\/dot.2004.40.8.850471","article-title":"Memantine hydrochloride: pharmacological and clinical profile.","volume":"40","author":"Mobius","year":"2004","journal-title":"Drugs Today (Barc)"},{"key":"R14-2-20210203","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/PL00007728","article-title":"Drug therapy for acquired pendular nystagmus in multiple sclerosis.","volume":"244","author":"Starck","year":"1997","journal-title":"J Neurol"},{"key":"R15-2-20210203","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1055\/s-2008-1069311","article-title":"Effects of oral memantine administration on Parkinson symptoms. Results of a placebo-controlled multicenter study.","volume":"109","author":"Schneider","year":"1984","journal-title":"Dtsch Med Wochenschr"},{"key":"R16-2-20210203","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/syn.20472","article-title":"Memantine agonist action at dopamine D2High receptors.","volume":"62","author":"Seeman","year":"2008","journal-title":"Synapse"},{"key":"R17-2-20210203","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1111\/j.0953-816X.2004.03297.x","article-title":"Involvement of the sigma1 receptor in the modulation of dopaminergic transmission by amantadine.","volume":"19","author":"Peeters","year":"2004","journal-title":"Eur J Neurosci"},{"key":"R18-2-20210203","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1248\/bpb.32.850","article-title":"Influence of memantineon brain monoaminergic neurotransmission parameters in mice: neurochemical and behavioral study.","volume":"32","author":"Onogi","year":"2009","journal-title":"Biol Pharm Bull"},{"key":"R20-2-20210203","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/1531-8257(200101)16:1<89::AID-MDS1001>3.0.CO;2-L","article-title":"A teaching videotape for the assessment of essential tremor.","volume":"16","author":"Louis","year":"2001","journal-title":"Mov Disord"},{"key":"R21-2-20210203","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/mds.20147","article-title":"Pilot efficacy and tolerability: a randomized, placebo-controlled trial of levetiracetam for essential tremor.","volume":"19","author":"Handforth","year":"2004","journal-title":"Mov Disord"},{"key":"R22-2-20210203","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1001\/archneur.56.4.475","article-title":"A randomized placebo-controlled comparative trial of gabapentin and propranolol in essential tremor.","volume":"56","author":"Gironell","year":"1999","journal-title":"Arch Neurol"},{"key":"R24-2-20210203","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/mds.870110306","article-title":"A randomized, double-blind, placebo controlled study to evaluate botulinum toxin type A in essential hand tremor.","volume":"11","author":"Jankovic","year":"1996","journal-title":"Mov Disord"},{"key":"R25-2-20210203","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/mds.22418","article-title":"Zonisamide for essential tremor: an evaluator-blinded study.","volume":"24","author":"Handforth","year":"2009","journal-title":"Mov Disord"},{"key":"R26-2-20210203","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1212\/01.wnl.0000188670.38576.bd","article-title":"A single-blind, open-label trial of sodium oxybate for myoclonus and essential tremor.","volume":"65","author":"Frucht","year":"2005","journal-title":"Neurology"},{"key":"R27-2-20210203","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1001\/archneurol.2009.217","article-title":"Essential tremors: a family of neurodegenerative disorders?","volume":"66","author":"Louis","year":"2009","journal-title":"Arch Neurol"}],"container-title":["Clinical Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/WNF.0b013e3181ebd109","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T07:14:37Z","timestamp":1620976477000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002826-201009000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/wnf.0b013e3181ebd109","relation":{},"ISSN":["0362-5664"],"issn-type":[{"value":"0362-5664","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}